23andMe Holding Co. (MEUSW)
NASDAQ: MEUSW
· Real-Time Price · USD
1.38
-0.13 (-8.61%)
At close: Apr 24, 2025, 3:47 PM
-8.61% (1D)
| Bid | n/a |
| Market Cap | 0 |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 235,963 |
| Avg. Volume (20D) | 188,428 |
| Open | 3.40 |
| Previous Close | 1.51 |
| Day's Range | 1.33 - 1.74 |
| 52-Week Range | 1.15 - 5.72 |
| Beta | 0.00 |
About MEUSW
23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development. It offers a crowdsourced platform that helps people to access, understand, and benefit from the human genome; access direct-to-consumer genetic testing; and give consumers personalized information about their genetic health risks, ancestry, and traits. The company ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 17, 2021
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol MEUSW
Website http://www.23andme.com